VistaGen Therapeutics

+$0.01 (+0.47%) Today
-$0.01 (-0.47%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell VTGN and other stocks, options, and ETFs commission-free!

About VTGN

VistaGen Therapeutics, Inc. Common Stock, also called VistaGen Therapeutics, is a clinical-stage biopharmaceutical company committed to developing and commercializing new generation medications that go beyond the current standard of care for anxiety, depression and other central nervous system (CNS) disorders.

CEO
Shawn K. Singh
Employees
9
Headquarters
South San Francisco, California
Founded
1998

VTGN Key Statistics

Market Cap
454.81M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.58M
High Today
$2.21
Low Today
$2.12
Open Price
$2.16
Volume
1.25M
52 Week High
$3.18
52 Week Low
$0.36

VTGN Earnings

-$0.15
-$0.10
-$0.05
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Jun 28, After Hours

You May Also Like

LCTD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure